Suppression of protein kinase C theta contributes to enhanced myogenesis In vitro via IRS1 and ERK1/2 phosphorylation

BMC Cell Biology

Volumn 14, Issue 1, 2013, Pages

  Marino, Joseph S ^a,c   Hinds, Terry D ^a   Potter, Rachael A ^b   Ondrus, Eric ^b   Onion, Jeremy L ^b   Dowling, Abigail ^a   McLoughlin, Thomas J ^b   Sanchez, Edwin R ^a   Hill, Jennifer W ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b UNIVERSITY OF TOLEDO   (United States)

^c UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

Insulin receptor substrate; Myoblast differentiation; Myoblast fusion; Protein kinase C

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 7; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C THETA;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUSION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; IN VITRO STUDY; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL FUSION; CELLS, CULTURED; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INSULIN RECEPTOR SUBSTRATE PROTEINS; ISOENZYMES; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE DEVELOPMENT; MUSCLE FIBERS, SKELETAL; MYOBLASTS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84884326083     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-14-39     Document Type: Article

References (51)

1. Hawke TJ, Garry DJ. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 2001, 91(2):534-551.
2. Abmayr SM, Pavlath GK. Myoblast fusion: lessons from flies and mice. Development 2012, 139(4):641-656. 10.1242/dev.068353, 3265056, 22274696.
3. Sabourin LA, Rudnicki MA. The molecular regulation of myogenesis. Clin Genet 2000, 57(1):16-25.
4. Boura-Halfon S, Zick Y. Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol Endocrinol Metab 2009, 296(4):E581-591. 10.1152/ajpendo.90437.2008, 18728222.
5. Gredinger E, Gerber AN, Tamir Y, Tapscott SJ, Bengal E. Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells. J Biol Chem 1998, 273(17):10436-10444. 10.1074/jbc.273.17.10436, 9553102.
6. Lawlor MA, Feng X, Everding DR, Sieger K, Stewart CE, Rotwein P. Dual control of muscle cell survival by distinct growth factor-regulated signaling pathways. Mol Cell Biol 2000, 20(9):3256-3265. 10.1128/MCB.20.9.3256-3265.2000, 85619, 10757809.
7. Madhala-Levy D, Williams VC, Hughes SM, Reshef R, Halevy O. Cooperation between Shh and IGF-I in promoting myogenic proliferation and differentiation via the MAPK/ERK and PI3K/Akt pathways requires Smo activity. J Cell Physiol 2012, 227(4):1455-1464. 10.1002/jcp.22861, 3360966, 21618536.
8. Sunadome K, Yamamoto T, Ebisuya M, Kondoh K, Sehara-Fujisawa A, Nishida E. ERK5 regulates muscle cell fusion through Klf transcription factors. Dev Cell 2011, 20(2):192-205. 10.1016/j.devcel.2010.12.005, 21316587.
9. Le Grand F, Grifone R, Mourikis P, Houbron C, Gigaud C, Pujol J, Maillet M, Pages G, Rudnicki M, Tajbakhsh S, et al. Six1 regulates stem cell repair potential and self-renewal during skeletal muscle regeneration. J Cell Biol 2012, 198(5):815-832. 10.1083/jcb.201201050, 3432771, 22945933.
10. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 2001, 3(11):1009-1013. 10.1038/ncb1101-1009, 11715022.
11. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 2001, 3(11):1014-1019. 10.1038/ncb1101-1014, 11715023.
12. Li Y, Soos TJ, Li X, Wu J, Degennaro M, Sun X, Littman DR, Birnbaum MJ, Polakiewicz RD. Protein kinase C Theta inhibits insulin signaling by phosphorylating IRS1 at Ser(1101). J Biol Chem 2004, 279(44):45304-45307. 10.1074/jbc.C400186200, 15364919.
13. Madaro L, Pelle A, Nicoletti C, Crupi A, Marrocco V, Bossi G, Soddu S, Bouche M. PKC theta ablation improves healing in a mouse model of muscular dystrophy. PLoS One 2012, 7(2):e31515. 10.1371/journal.pone.0031515, 3279361, 22348094.
14. Boczan J, Biro T, Czifra G, Lazar J, Papp H, Bardos H, Adany R, Mechler F, Kovacs L. Phorbol ester treatment inhibits proliferation and differentiation of cultured human skeletal muscle satellite cells by differentially acting on protein kinase C isoforms. Acta Neuropathol 2001, 102(1):55-62.
15. Kim SS, Kim JH, Kim HS, Park DE, Chung CH. Involvement of the theta-type protein kinase C in translocation of myristoylated alanine-rich C kinase substrate (MARCKS) during myogenesis of chick embryonic myoblasts. Biochem J 2000, 347(Pt 1):139-146. 1220941, 10727412.
16. Madaro L, Marrocco V, Fiore P, Aulino P, Smeriglio P, Adamo S, Molinaro M, Bouche M. PKCtheta signaling is required for myoblast fusion by regulating the expression of caveolin-3 and beta1D integrin upstream focal adhesion kinase. Mol Biol Cell 2011, 22(8):1409-1419. 10.1091/mbc.E10-10-0821, 3078083, 21346196.
17. Meller N, Altman A, Isakov N. New perspectives on PKCtheta, a member of the novel subfamily of protein kinase C. Stem Cells 1998, 16(3):178-192. 10.1002/stem.160178, 9617893.
18. Baier G, Telford D, Giampa L, Coggeshall KM, Baier-Bitterlich G, Isakov N, Altman A. Molecular cloning and characterization of PKC theta, a novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells. J Biol Chem 1993, 268(7):4997-5004.
19. Osada S, Mizuno K, Saido TC, Suzuki K, Kuroki T, Ohno S. A new member of the protein kinase C family, nPKC theta, predominantly expressed in skeletal muscle. Mol Cell Biol 1992, 12(9):3930-3938. 360273, 1508194.
20. Turban S, Hajduch E. Protein kinase C isoforms: mediators of reactive lipid metabolites in the development of insulin resistance. FEBS Lett 2011, 585(2):269-274. 10.1016/j.febslet.2010.12.022, 21176778.
21. Wang C, Liu M, Riojas RA, Xin X, Gao Z, Zeng R, Wu J, Dong LQ, Liu F. Protein kinase C theta (PKCtheta)-dependent phosphorylation of PDK1 at Ser504 and Ser532 contributes to palmitate-induced insulin resistance. J Biol Chem 2009, 284(4):2038-2044.
22. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 2002, 277(52):50230-50236. 10.1074/jbc.M200958200, 12006582.
23. Boczan J, Boros S, Mechler F, Kovacs L, Biro T. Differential expressions of protein kinase C isozymes during proliferation and differentiation of human skeletal muscle cells in vitro. Acta Neuropathol 2000, 99(2):96-104. 10.1007/PL00007429, 10672314.
24. Hilgenberg L, Yearwood S, Milstein S, Miles K. Neural influence on protein kinase C isoform expression in skeletal muscle. J Neurosci 1996, 16(16):4994-5003.
25. Miles K, Wagner M. Overexpression of nPKC theta is inhibitory for agrin-induced nicotinic acetylcholine receptor clustering in C2C12 myotubes. J Neurosci Res 2003, 71(2):188-195. 10.1002/jnr.10467, 12503081.
26. Kim S, Bondeva T, Nelson PG. Activation of protein kinase C isozymes in primary mouse myotubes by carbachol. Brain Res Dev Brain Res 2002, 137(1):13-21. 10.1016/S0165-3806(02)00362-0, 12128250.
27. Burks TN, Andres-Mateos E, Marx R, Mejias R, Van Erp C, Simmers JL, Walston JD, Ward CW, Cohn RD. Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia. Sci Transl Med 2011, 3(82):82ra37. 10.1126/scitranslmed.3002227, 3140459, 21562229.
28. Burks TN, Cohn RD. Role of TGF-beta signaling in inherited and acquired myopathies. Skelet Muscle 2011, 1(1):19. 10.1186/2044-5040-1-19, 3156642, 21798096.
29. Zappelli F, Willems D, Osada S, Ohno S, Wetsel WC, Molinaro M, Cossu G, Bouche M. The inhibition of differentiation caused by TGFbeta in fetal myoblasts is dependent upon selective expression of PKCtheta: a possible molecular basis for myoblast diversification during limb histogenesis. Dev Biol 1996, 180(1):156-164. 10.1006/dbio.1996.0292, 8948582.
30. Miles K, Wagner M. Overexpression of nPKC theta is permissive for myogenic differentiation. J Cell Biochem 2000, 79(1):71-79. 10.1002/1097-4644(2000)79:1<71::AID-JCB70>3.0.CO;2-N, 10906756.
31. Park IH, Chen J. Mammalian target of rapamycin (mTOR) signaling is required for a late-stage fusion process during skeletal myotube maturation. J Biol Chem 2005, 280(36):32009-32017. 10.1074/jbc.M506120200, 16043480.
32. Meissner JD, Freund R, Krone D, Umeda PK, Chang KC, Gros G, Scheibe RJ. Extracellular signal-regulated kinase 1/2-mediated phosphorylation of p300 enhances myosin heavy chain I/beta gene expression via acetylation of nuclear factor of activated T cells c1. Nucleic Acids Res 2011, 39(14):5907-5925. 10.1093/nar/gkr162, 3152325, 21498542.
33. Mermelstein CS, Martins ER, Portilho DM, Costa ML. Association between the muscle-specific proteins desmin and caveolin-3 in muscle cells. Cell Tissue Res 2007, 327(2):343-351.
34. Quach NL, Biressi S, Reichardt LF, Keller C, Rando TA. Focal adhesion kinase signaling regulates the expression of caveolin 3 and beta1 integrin, genes essential for normal myoblast fusion. Mol Biol Cell 2009, 20(14):3422-3435. 10.1091/mbc.E09-02-0175, 2710835, 19458188.
35. Marino JS, Tausch BJ, Dearth CL, Manacci MV, McLoughlin TJ, Rakyta SJ, Linsenmayer MP, Pizza FX. Beta2-integrins contribute to skeletal muscle hypertrophy in mice. Am J Physiol Cell Physiol 2008, 295(4):C1026-1036. 10.1152/ajpcell.212.2008, 18753316.
36. Sutcliffe EL, Bunting KL, He YQ, Li J, Phetsouphanh C, Seddiki N, Zafar A, Hindmarsh EJ, Parish CR, Kelleher AD, et al. Chromatin-associated protein kinase C-theta regulates an inducible gene expression program and microRNAs in human T lymphocytes. Mol Cell 2011, 41(6):704-719. 10.1016/j.molcel.2011.02.030, 21419345.
37. Bauer B, Krumbock N, Fresser F, Hochholdinger F, Spitaler M, Simm A, Uberall F, Schraven B, Baier G. Complex formation and cooperation of protein kinase C theta and Akt1/protein kinase B alpha in the NF-kappa B transactivation cascade in Jurkat T cells. J Biol Chem 2001, 276(34):31627-31634. 10.1074/jbc.M103098200, 11410591.
38. Tureckova J, Wilson EM, Cappalonga JL, Rotwein P. Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J Biol Chem 2001, 276(42):39264-39270. 10.1074/jbc.M104991200, 11500504.
39. Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, Reid K, Moelling K, Yancopoulos GD, Glass DJ. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 1999, 286(5445):1738-1741. 10.1126/science.286.5445.1738, 10576741.
40. Mothe I, Van Obberghen E. Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action. J Biol Chem 1996, 271(19):11222-11227. 10.1074/jbc.271.19.11222, 8626671.
41. Gual P, Le Marchand-Brustel Y, Tanti JF. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 2005, 87(1):99-109. 10.1016/j.biochi.2004.10.019, 15733744.
42. Lee HJ, Bae GU, Leem YE, Choi HK, Kang TM, Cho H, Kim ST, Kang JS. Phosphorylation of Stim1 at serine 575 via netrin-2/Cdo-activated ERK1/2 is critical for the promyogenic function of Stim1. Mol Biol Cell 2012, 23(7):1376-1387. 10.1091/mbc.E11-07-0634, 3315807, 22298426.
43. Hiratani K, Haruta T, Tani A, Kawahara J, Usui I, Kobayashi M. Roles of mTOR and JNK in serine phosphorylation, translocation, and degradation of IRS-1. Biochemical and biophysical research communications 2005, 335(3):836-842. 10.1016/j.bbrc.2005.07.152, 16099428.
44. Purushothaman A, Babitz SK, Sanderson RD. Heparanase enhances the insulin receptor signaling pathway to activate extracellular signal-regulated kinase in multiple myeloma. J Biol Chem 2012, 287(49):41288-41296. 10.1074/jbc.M112.391417, 23048032.
45. Bouzakri K, Roques M, Gual P, Espinosa S, Guebre-Egziabher F, Riou JP, Laville M, Le Marchand-Brustel Y, Tanti JF, Vidal H. Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. Diabetes 2003, 52(6):1319-1325. 10.2337/diabetes.52.6.1319, 12765939.
46. Diaz-Rodriguez E, Pandiella A. Multisite phosphorylation of Erk5 in mitosis. J Cell Sci 2010, 123(Pt 18):3146-3156.
47. Inesta-Vaquera FA, Campbell DG, Tournier C, Gomez N, Lizcano JM, Cuenda A. Alternative ERK5 regulation by phosphorylation during the cell cycle. Cell Signal 2010, 22(12):1829-1837. 10.1016/j.cellsig.2010.07.010, 20667468.
48. Winter JN, Fox TE, Kester M, Jefferson LS, Kimball SR. Phosphatidic acid mediates activation of mTORC1 through the ERK signaling pathway. Am J Physiol Cell Physiol 2010, 299(2):C335-344. 10.1152/ajpcell.00039.2010, 2928642, 20427710.
49. Goodman CA, Miu MH, Frey JW, Mabrey DM, Lincoln HC, Ge Y, Chen J, Hornberger TA. A phosphatidylinositol 3-kinase/protein kinase B-independent activation of mammalian target of rapamycin signaling is sufficient to induce skeletal muscle hypertrophy. Mol Biol Cell 2010, 21(18):3258-3268. 10.1091/mbc.E10-05-0454, 2938390, 20668162.
50. Sarbassov DD, Peterson CA. Insulin receptor substrate-1 and phosphatidylinositol 3-kinase regulate extracellular signal-regulated kinase-dependent and -independent signaling pathways during myogenic differentiation. Mol Endocrinol 1998, 12(12):1870-1878. 10.1210/me.12.12.1870, 9849961.
51. Hinds TD, Ramakrishnan S, Cash HA, Stechschulte LA, Heinrich G, Najjar SM, Sanchez ER. Discovery of glucocorticoid receptor-beta in mice with a role in metabolism. Mol Endocrinol 2010, 24(9):1715-1727. 10.1210/me.2009-0411, 2940475, 20660300.